◀ Back to MAPK1
ATF3 — MAPK1
Text-mined interactions from Literome
Yosimichi et al., Eur J Biochem 2001
:
These inhibitors of MAPKK and
MAPK suppressed phosphorylation of ets-like gene-1 (Elk-1) and nuclear
activating transcription factor-2 ( Atf-2 ) induced by CTGF/Hcs24 in a dose dependent manner, respectively
Faour et al., J Biol Chem 2005
(Arthritis, Rheumatoid) :
Initial studies confirmed that PGE2 induces egr-1 mRNA expression and protein synthesis by restricted SAPK2/p38
MAPK dependent
activating transcription factor-2 ( ATF-2) dimer transactivation of the egr-1 promoter as judged by studies using wild-type ( WT ) and deletion mutant egr-1 promoter constructs, Northern and Western blotting, and standard and supershift electrophoretic mobility shift analyses
Bottone et al., J Pharmacol Exp Ther 2005
:
These compounds
induced phosphorylation of
extracellular signal regulated kinase1/2 ( Erk1/2 ), whereas a dominant negative inhibitor of mitogen-activate protein kinase kinase ( MEK) 1 blocked the induction of
ATF3
Hisatsune et al., J Immunol 2008
:
Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent
role for
p38MAPK in
activating transcription factor-2 , cAMP response element binding protein, and NF-kappaB activation
Cho et al., Mol Endocrinol 2009
:
The inhibition of
MAPK dependent
activating transcription factor 2/c-Jun phosphorylation by GR in COX-2 repression was a result of MAPK phosphatase-1 (MKP-1) induction
St Germain et al., Neoplasia (New York, N.Y.) 2010
(MAP Kinase Signaling System) :
MAPK pathway inhibition
led to decreased
ATF3 messenger RNA expression and reduced cytotoxic effects of cisplatin as measured by the 3- ( 4,5-dimethylthiazol-2-yl ) -2,5-diphenyltetrazolium bromide cell viability assay